Latest Breaking News On - Med systems - Page 7 : comparemela.com

Repro Med (KRMD): Top Detractor for Roubaix Capital in Q4’20 Roubaix Capital LLC, an investment management firm, published its ‘Roubaix Fund Composite’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 26.63% was recorded by the fund for the Q4 of 2020, outperforming its HFRI Equity Hedge benchmark that delivered a 14.50% return but below its Russell 2000 index that had a 31.37% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Roubaix Capital, in their Q4 2020 Investor Letter, said that Repro Med Systems, Inc. (NASDAQ: KRMD) was the largest detractor for their portfolio in the fourth quarter of 2020. Repro Med Systems, Inc. is a medical device designer and manufacturing company that currently has a $192 million market cap. For the past 3 months, KRMD delivered a 9.25% return and settled at $4.37 per share at the closing of February 12th.

Chaikom shutterstockRoubaix capitalRoubaix fundRepro med systems incFederal reserveRoubaix fund compositeRepro med systemsMed systemsAmong hedgeInsider monkeyFree daily newsletterரௌபகஷ மூலதனம்ரௌபகஷ நிதிரிப்ரோ மேட் அமைப்புகள் இன்க்கூட்டாட்சியின் இருப்புரௌபகஷ நிதி கலப்பு